Abstract:Background: Sclerotherapy is a non-invasive procedure commonly used to treat superficial venous disease, vascular malformations and other ectatic vascular lesions. While extremely rare, sclerotherapy may be complicated by serious adverse events. Objectives: To categorise contraindications to sclerotherapy based on the available scientific evidence. Methods: An international, multi-disciplinary panel of phlebologists reviewed the available scientific evidence and developed consensus where evidence was lacking or limited. Results: Absolute Contraindications to sclerotherapy where the risk of harm would outweigh any benefits include known hypersensitivity to sclerosing agents; acute venous thromboembolism (VTE); severe neurological or cardiac adverse events complicating a previous sclerotherapy treatment; severe acute systemic illness or infection; and critical limb ischaemia. Relative Contraindications to sclerotherapy where the potential benefits of the proposed treatment would outweigh the risk of harm or the risks may be mitigated by other measures include pregnancy, postpartum and breastfeeding; hypercoagulable states with risk of VTE; risk of neurological adverse events; risk of cardiac adverse events and poorly controlled chronic systemic illness. Conditions and circumstances where Warnings and Precautions should be considered before proceeding with sclerotherapy include risk of cutaneous necrosis or cosmetic complications such as pigmentation and telangiectatic matting; intake of medications such as the oral contraceptive and other exogenous oestrogens, disulfiram and minocycline; and psychosocial factors and psychiatric comorbidities that may increase the risk of adverse events or compromise optimal treatment outcomes. Conclusions: Sclerotherapy can achieve safe clinical outcomes provided that (1) patient-related risk factors and in particular all material risks are (1a) adequately identified and the risk benefit ratio is clearly and openly discussed with treatment candidates within a reasonable timeframe prior to the actual procedure; (1b) when an individual is not a suitable candidate for the proposed intervention, conservative treatment options including the option of 'no intervention as a treatment option' are discussed; (1c) complex cases are referred for treatment in controlled and standardised settings and by practitioners with more expertise in the field; (1d) only suitable individuals with no absolute contraindications or those with relative contraindications where the benefits outweigh the risks are offered intervention; (1e) if proceeding with intervention, appropriate prophylactic measures and other risk-mitigating strategies are adopted and appropriate follow-up is organised; and (2) procedure-related risk factors are minimised by ensuring the treating physicians (2a) have adequate training in general phlebology with additional training in duplex ultrasound, procedural phlebology and in particular sclerotherapy; (2b) maintain their knowledge and competency over time and (2c) review and optimise their treatment strategies and techniques on a regular basis to keep up with the ongoing progress in medical technology and contemporary scientific evidence.

Cryo Laser and Cryo Sclerotherapy (CLaCS) for the Treatment of Spider Veins in India

Case report: Novel leg vein treatment CLaCS guided by augmented reality 11 years follow-up

Treatment of varicose veins using the Cryo laser after foam technique

Cryosclerosis. A forgotten endovenous procedure for treating the incompetence of the great saphenous vein. Short term results

Combination Foam and Liquid Sclerotherapy for Lower Extremity Reticular and Telangiectatic Veins: A Single-Center Retrospective Study

Endovenous laser ablation and concomitant foam sclerotherapy: experience in 504 patients

Treatment of Telangiectasia and Reticular Veins of Lower Limb : Experience with Sclerotherapy and the Long-Pulsed 1064 nm Nd : YAG Laser in China

Treatment of Telangiectasia and Varicose Vein of Lower Limb: Experience with Foam Sclerotherapy and the Long-Pulsed 1064 Nm Nd∶YAG Laser

Safety and Efficacy of Combining Saphenous Endovenous Laser Ablation and Varicose Veins Foam Sclerotherapy: An Analysis on 5500 Procedures in Patients With Advance Chronic Venous Disease (C3-C6)

Comparison of acceptability & efficacy of thermal ablation (thermocoagulation) & cryotherapy in VIA positive cervical lesions: A pilot study

Protocols designing of treating varicose veins of the lower extremity by combining surgery and sclerotherapy, report of 31 cases

Fluoroscopy-guided foam sclerotherapy for varicose veins in the legs: a retrospective cohort analysis with long-term follow-up

Evaluation of Endovenous Laser Ablation in the Management of Varicose Veins

Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023

Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins

A 1470-Nm Laser Combined with Foam Sclerotherapy in Day Surgery: a Better Choice for Lower Limb Varicose Veins

[State of crural perforating veins after sclerosurgical interventions for lower limb varicose disease]

Endovenous laser treatment combined with a surgical strategy for treatment of venous insufficiency in lower extremity: a report of 208 cases.

Clinical outcomes of nonthermal ablation, thermal ablation, and surgical stripping for varicose veins

The significance of minimally invasive treatment methods in the single-stage elimination of varicose vein disease of the great and small saphenous veins of the lower limbs and their branches

Endovenous Laser Treatment of Superficial Varicosities of the Lower Limbs(Report of 92 Cases)